Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 75% of sites...
Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.21 | -11.5384615385 | 1.82 | 1.82 | 1.59 | 248063 | 1.67265165 | CS |
| 4 | 0.01 | 0.625 | 1.6 | 1.82 | 1.55 | 204500 | 1.66776433 | CS |
| 12 | 0.08 | 5.22875816993 | 1.53 | 1.82 | 1.448 | 204709 | 1.57509421 | CS |
| 26 | -0.55 | -25.462962963 | 2.16 | 2.23 | 1.4 | 308595 | 1.65275886 | CS |
| 52 | -0.61 | -27.4774774775 | 2.22 | 3.47 | 1.4 | 412226 | 1.8429641 | CS |
| 156 | -23.15 | -93.4975767367 | 24.76 | 25.85 | 1.175 | 639968 | 9.42516186 | CS |
| 260 | -33.44 | -95.4065620542 | 35.05 | 63.22 | 1.175 | 537128 | 12.7908876 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
